News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
FDA
Bayer Corporation Gets Japan Approval for Kidney Cancer Drug
January 28, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
TOKYO, Jan 28 (Reuters) - German drug maker Bayer AG said on Monday its drug Nexavar had been approved in Japan for the treatment of advanced kidney cancer, beating rival makers of similar therapies to the market here.
Twitter
LinkedIn
Facebook
Email
Print
FDA
Approvals
Asia
Bayer
MORE ON THIS TOPIC
Collaboration
GSK Joins Growing PD-1 SubQ Push With Alteogen Alliance Worth up to $285M+
January 21, 2026
·
1 min read
·
Tristan Manalac
Podcast
JPM26 Recap, Novo’s Oral Wegovy Soars as Lilly’s Orforglipron Is Delayed, IPOs Return
January 21, 2026
·
1 min read
·
Heather McKenzie
Manufacturing
CDMOs Pin Hopes for Accelerating Uptake at New US Sites on FDA’s PreCheck Program
January 20, 2026
·
4 min read
·
Nick Paul Taylor
IN PARTNERSHIP WITH LOTTE BIOLOGICS
LOTTE Biologics Tightens Global Quality as Syracuse ADC Hub Ramps for 2026
January 19, 2026
·
2 min read
·
Jennifer Smith-Parker
